007 Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies. (1st July 2018) - Clayton, A.H.; Kingsberg, S.A.; Simon, J.; Jordan, R.; Lucas, J.